CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 114 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 3.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $56,000 | -30.9% | 17,125 | -10.5% | 0.00% | – |
| Q2 2021 | $81,000 | +42.1% | 19,125 | +67.3% | 0.00% | – |
| Q1 2021 | $57,000 | -81.4% | 11,432 | -53.0% | 0.00% | -100.0% |
| Q4 2020 | $307,000 | +28.5% | 24,305 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $239,000 | -12.8% | 24,305 | -11.6% | 0.00% | -50.0% |
| Q2 2020 | $274,000 | +12.8% | 27,505 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $243,000 | +30.6% | 27,505 | +36.7% | 0.00% | +100.0% |
| Q4 2019 | $186,000 | -23.5% | 20,116 | +39.2% | 0.00% | 0.0% |
| Q2 2018 | $243,000 | -58.9% | 14,447 | -44.0% | 0.00% | -66.7% |
| Q1 2018 | $591,000 | +485.1% | 25,807 | +562.1% | 0.00% | – |
| Q4 2017 | $101,000 | – | 3,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |